Anmeldung erfolgt in Kürze...
Details werden geladen...
ENTOD Pharmaceuticals secures patent for its insulin eye drop - The Economic Times
Currently at the pre-clinical stage of development, the patented insulin eye drops are being investigated as a potential novel therapeutic approach to address unmet needs in ophthalmic care, the Mumbai-based company said.
Ähnliche Seiten
Doctors' safety alert led to Sun Pharma eye drop recall - The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-pharma-recalls-11-eyecare-products-amid-serious-bacterial-contamination-concerns/articleshow/133134589.cms
Provectus Biopharmaceuticals and VisiRose Announce U.S. Patent Award for Light-Independent Antibacterial Eye Drop Targeting Drug-Resistant Ocular Infections | The Manila Times
https://www.manilatimes.net/2026/06/30/tmt-newswire/globenewswire/provectus-biopharmaceuticals-and-visirose-announce-us-patent-award-for-light-independent-antibacterial-eye-drop-targeting-drug-resistant-ocular-infections/2375707Incannex Secures U.S. Patent Grant for IHL-42X in Obstructive Sleep Apnea | The Manila Times
https://www.manilatimes.net/2026/06/25/tmt-newswire/globenewswire/incannex-secures-us-patent-grant-for-ihl-42x-in-obstructive-sleep-apnea/2372797MacroGenics to Receive Milestone Payment from Sanofi for Recent TZIELD® Approval | The Manila Times
https://www.manilatimes.net/2026/06/23/tmt-newswire/globenewswire/macrogenics-to-receive-milestone-payment-from-sanofi-for-recent-tzield-approval/2370486
Ascentage Pharma Presents Updated Clinical Data for Olverembatinib as Second-Line Therapy in CML-CP at ASCO 2026 | The Manila Times
https://www.manilatimes.net/2026/06/01/tmt-newswire/globenewswire/ascentage-pharma-presents-updated-clinical-data-for-olverembatinib-as-second-line-therapy-in-cml-cp-at-asco-2026/2355278